Table 3 Estimated life expectancies at birth for individuals with CP stratified by level of physical disability, as well as maximum and minimum values used in the sensitivity analyses
From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Estimated life expectancy (years) | Min | Max | |
|---|---|---|---|
Mild (GMFCS level I/II) | 81 | 71 | 91 |
Moderate (GMFCS level III) | 66 | 56 | 76 |
Severe (GMFCS level IV/V) | 25 | 20 | 30 |